Brought to you by 
Zimmer pays $13.35bn in cash and stock for Biomet
10 Sep 2020
Executive Summary
Positioning itself to become a top competitor in the $45bn musculoskeletal market, Zimmer Holdings Inc. bought public orthopedic device maker Biomet Inc. for $13.35bn--$10.35bn in cash and $3bn in Zimmer stock. Zimmer plans to refinance some of its own debt, including an existing $250mm in notes due 2014, in addition to certain Biomet debt.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Zimmer pays $13.35bn in cash and stock for Biomet
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice